← FDA DRUG APPROVALS

FDA NDA · NDA018289

NEPHROFLOW

Sponsor: GE HEALTHCARE

APPLICATION
NDA018289
TYPE
NDA
ORIGINAL APPROVAL
1984-12-28
LATEST ACTION
1984-12-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NEPHROFLOWDiscontinued
IODOHIPPURATE SODIUM I-123 1mCi/ML · INJECTABLE · INJECTION

Approval history

1984-12-28Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →